Product |
CAS |
Molecular formula |
More |
N-pyridin-2-ylmethyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)- |
864754-23-4 |
C19H23BN2O3 |
More |
N-pyridin-3-ylmethyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)- |
864754-24-5 |
C19H23BN2O3 |
More |
N-pyridin-4-ylmethyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)- |
864754-25-6 |
C19H23BN2O3 |
More |
N-(1-dimethylamino-ethylidene)-2-ethyl-thioisonicotinamide |
864754-43-8 |
C12H17N3S |
More |
N-(4-methyl-pyridin-2-yl)-4-(4,4,5,5-tetramethyl -[1,3,2]dioxaborolan- |
864754-46-1 |
C19H23BN2O3 |
More |
N-(3-methyl-isothiazol-5-yl)-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborola |
864754-51-8 |
C17H21BN2O3S |
More |
N-pyridin-4-yl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzam |
864759-38-6 |
C18H21BN2O3 |
More |
N-methyl-n-pyridin-2-yl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-y |
864759-39-7 |
C19H23BN2O3 |
More |
N-(2-chloro-pyridin-3-yl)-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2 |
864759-40-0 |
C18H20BClN2O3 |
More |
N-(6-methoxy-pyridin-3-yl)-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan- |
864759-41-1 |
C19H23BN2O4 |
More |
N-methyl-n-(2-pyridin-2-yl-ethyl)-4-(4,4,5,5-tetramethyl-[1,3,2]dioxab |
864759-42-2 |
C21H27BN2O3 |
More |
N-ethyl-n-pyridin-4-ylmethyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborola |
864759-43-3 |
C21H27BN2O3 |
More |
N-(2-cyano-ethyl)-n-pyridin-3-ylmethyl-4-(4,4,5,5-tetramethyl-[1,3,2]d |
864759-44-4 |
C22H26BN3O3 |
More |
N-(3-azepan-1-yl-propyl)-4-iodo-benzenesulfonamide hydrochloride |
864759-52-4 |
C15H23IN2O2S.ClH |
More |
N-(1-ethyl-pyrrolidin-2-ylmethyl)-4-iodo-benzenesulfonamide hydrochlor |
864759-53-5 |
C13H19IN2O2S.ClH |
More |
2-N-propoxypyridine-3-carboxaldehyde |
865278-12-2 |
C9H11NO2 |
More |
N-methyl-n-[(1-phenyl-1h-pyrazol-4-yl)methyl]amine |
868552-05-0 |
C11H13N3 |
More |
1,8-Naphthyridine,5-azido-2-methyl-6-(phenylmethyl)- |
868695-86-7 |
C16H13N5 |
More |
N-methyl-n-4-piperidinyl-benzeneacetamide |
868764-37-8 |
C14H20N2O |
More |
N-(cyclohexylmethyl)-n-methyl-4-piperidinamine |
868770-08-5 |
C13H26N2 |
More |
|